Crispr Therapeutics AG(CH:1CG)
CHF 35.04+0.05 (+0.15%)
CH:1CG
Crispr Therapeutics AG earnings date
CHF 35.04
At close:+0.05 (+0.15%)
Crispr Therapeutics AG (1CG) Q2 2021 Earnings Report
2 Followers
CH:1CG Q2 2021 EPS Results
- Actual EPS
- CHF 7.79
- Consensus EPS
- CHF 2.91
- Beat/Miss
- Beat by +CHF 4.88
- One Year Ago EPS
- -CHF 1.07
CH:1CG Q2 2021 Revenue Results
- Actual Revenue
- CHF 743.46M
- Expected Revenue
- CHF 743.04M
- Beat/Miss
- Beat by +CHF 425.09K
- YoY Revenue Growth
- +2046947.73%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/29/2021
- Time
- After Close
- Conference Call
- Thursday, July 29, 2021
CH:1CG Upcoming Earnings
Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:1CG Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | -0.97- | -1.13 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.86-0.95 | -0.97 | 1.71% (+0.02) | |
| Aug 03, 2026 | 2026 (Q2) | -0.99-0.78 | -1.98 | 60.83% (+1.21) | |
| May 04, 2026 | 2026 (Q1) | -1.01-1.06 | -1.3 | 18.99% (+0.25) | |
| Feb 12, 2026 | 2025 (Q4) | -0.96-1.13 | -0.36 | -211.36% (-0.77) | |
| Nov 10, 2025 | 2025 (Q3) | -1.04-0.97 | -0.83 | -15.84% (-0.13) | |
| Aug 04, 2025 | 2025 (Q2) | -1.16-1.98 | -1.23 | -61.07% (-0.75) | |
| May 06, 2025 | 2025 (Q1) | -1.03-1.30 | -1.18 | -10.49% (-0.12) | |
| Feb 11, 2025 | 2024 (Q4) | -0.99-0.36 | 0.91 | -140.00% (-1.27) | |
| Nov 05, 2024 | 2024 (Q3) | -1.16-0.83 | -1.16 | 28.37% (+0.33) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

